Enrolling adolescents in disease/target-appropriate adult oncology clinical trials of investigational agents

44Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

The enrollment of adolescents with cancer in clinical trials is much lower than that of younger pediatric patients. For adolescents with "adult-type" cancers, lack of access to relevant trials is cited as one of the reasons for this discrepancy. Adolescents are generally not eligible for enrollment in adult oncology trials, and initial pediatric trials for many drugs are conducted years later, often after the drug is approved. As a result, accrual of adolescents to these trials may be slow due to off-label use, prospectively collected safety and efficacy data are lacking at the time of initial approval, and, most importantly, these adolescents have delayed access to effective therapies. To facilitate earlier access to investigational and approved drugs for adolescent patients with cancer, and because drug exposure is most often similar in adolescents and adults, we recommend the inclusion of adolescents (ages 12-17) in disease- and target-appropriate adult oncology trials. This approach requires careful monitoring for any differential safety signals, appropriate pharmacokinetic evaluations, and ensuring that ethical requirements are met. Inclusion of adolescents in adult oncology trials will require the cooperation of investigators, cooperative groups, industry, institutional review boards, and regulatory agencies to overcome real and perceived barriers.

References Powered by Scopus

Developmental pharmacology - Drug disposition, action, and therapy in infants and children

1939Citations
N/AReaders
Get full text

The distinctive biology of cancer in adolescents and young adults

522Citations
N/AReaders
Get full text

Declining childhood and adolescent cancer mortality

407Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Broadening eligibility criteria to make clinical trials more representative: American society of clinical oncology and friends of cancer research joint research statement

340Citations
N/AReaders
Get full text

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)

137Citations
N/AReaders
Get full text

Precision medicine in pediatric oncology

109Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chuk, M. K., Mulugeta, Y., Roth-Cline, M., Mehrotra, N., & Reaman, G. H. (2017). Enrolling adolescents in disease/target-appropriate adult oncology clinical trials of investigational agents. Clinical Cancer Research, 23(1), 9–12. https://doi.org/10.1158/1078-0432.CCR-16-1367

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

53%

Researcher 6

35%

Professor / Associate Prof. 2

12%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

63%

Pharmacology, Toxicology and Pharmaceut... 3

16%

Agricultural and Biological Sciences 2

11%

Biochemistry, Genetics and Molecular Bi... 2

11%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 17

Save time finding and organizing research with Mendeley

Sign up for free
0